Floy® precisely and fully automatically measures brain region volumes in MRI, comparing them with age- and sex-specific normative cohorts to enable early diagnosis of neurodegenerative diseases such as various forms of dementia.
Learn more
Floy® fully automatically detects and measures multiple sclerosis (MS) lesions in brain MRI, including comparison with prior scans, to support precise MS diagnosis.
Learn more
Floy® precisely and fully automatically measures the volume of organs, abdominal wall muscles, and subcutaneous and visceral fat in abdominal MRI and CT scans. This enables early detection of metabolic disorders and health risk factors.
Floy® detects, classifies, and measures potentially malignant lung lesions in chest CT, including comparison with prior scans, to enable early identification of signs of lung cancer.
Learn more
Floy® detects and classifies potentially malignant spinal lesions in MRI and CT, enabling early and highly accurate tumor identification.
Learn more
Floy® detects and classifies potentially malignant breast tissue changes in planar mammography to enable early and precise identification of signs of breast cancer.
